United States: FTC's Campaign Against Improper Orange Book Listings Continues With Amicus Brief In Teva's Challenge Of Amneal Asthma Inhaler ANDA - Sheppard Mullin Richter & Hampton

Credit: Mondaq- Published on April 11, 2024

The Federal Trade Commission ("FTC") has filed an amicus brief in Teva Branded Pharmaceuticals Products R&D, Inc. v. Amneal Pharmaceuticals of New York, LLC to further the agency's...

👓 View full article:

You are here

› Legal › United States: FTC's Campaign Against Improper Orange Book Listings Continues With Amicus Brief In Teva's Challenge Of Amneal Asthma Inhaler ANDA - Sheppard Mullin Richter & Hampton

Related videos from verified sources

Our Time To Choose: The Institution or The Constitution | The Rob Maness Show EP 334 01:17

Credit: Rumble - Published on April 11, 2024

US Historians Inform Supreme Court That They Reject Trump’s Immunity Claim 01:31

Credit: Wibbitz Top Stories - Published on April 10, 2024

China-Based Hackers Hit With Sanctions and Indictments Over Cyber Attacks 01:30

Credit: Wibbitz Top Stories - Published on March 25, 2024

You might like